FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568967701> ?p ?o ?g. }

• W2568967701 endingPage "562" @default.
• W2568967701 startingPage "555" @default.
• W2568967701 abstract "The neutrophil-to-lymphocyte ratio (NLR), a measure of systemic inflammatory response, has been associated with poor outcome in several solid tumors, including prostate cancer. We retrospectively investigated the prognostic role of pretreatment NLR in metastatic castration-resistant prostate cancer (mCRPC) patients treated with first-line docetaxel.All CRPC patients treated with first-line docetaxel at two Italian institutions, with available data about baseline neutrophil and lymphocyte values, were included in this retrospective analysis. Patients were divided in two groups according to NLR ratio (low NLR: ≤3; high NLR: >3). Outcome measures were progression-free (PFS) and overall survival (OS), measured from the start of docetaxel treatment. Univariate and multivariate analysis (adjusting for baseline prostate-specific antigen, alkaline phosphatase, lactate dehydrogenase, hemoglobin, albumin, performance status, use of opioids and presence of visceral disease) were performed.One hundred and seventy-nine patients treated between 2004 and 2016 were analyzed and 110 had information about pretreatment NLR. Forty-six patients (42%) had low NLR and 64 (58%) had high NLR. Median PFS was 8.8 months in patients with low NLR versus 7.3 months in those with high NLR [hazard ratio (HR) 1.12, 95% confidence interval (CI) 0.75-1.69, p = .58]. Median OS was 34.9 months in patients with low NLR versus 20.2 months in those with high NLR (HR 1.85, 95% CI 1.07-3.19, p = .02). At multivariate analysis, NLR confirmed an independent impact on OS (HR 3.16, 95% CI 1.50-6.65, p = .002).In this retrospective series, metastatic CRPC patients who started first-line docetaxel with a low pretreatment NLR had a significantly better survival. In addition to known prognostic factors, NLR can be useful to improve prognostic evaluation of patients in this setting." @default.
• W2568967701 created "2017-01-13" @default.
• W2568967701 creator A5005198439 @default.
• W2568967701 creator A5005250000 @default.
• W2568967701 creator A5007575010 @default.
• W2568967701 creator A5030345469 @default.
• W2568967701 creator A5056829099 @default.
• W2568967701 creator A5058429184 @default.
• W2568967701 creator A5068091192 @default.
• W2568967701 creator A5070036041 @default.
• W2568967701 creator A5079802303 @default.
• W2568967701 creator A5087054688 @default.
• W2568967701 date "2017-01-09" @default.
• W2568967701 modified "2023-09-29" @default.
• W2568967701 title "Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel" @default.
• W2568967701 cites W2004973733 @default.
• W2568967701 cites W2004999965 @default.
• W2568967701 cites W2055346449 @default.
• W2568967701 cites W2091553144 @default.
• W2568967701 cites W2095914632 @default.
• W2568967701 cites W2102144390 @default.
• W2568967701 cites W2103090668 @default.
• W2568967701 cites W2110534364 @default.
• W2568967701 cites W2117783793 @default.
• W2568967701 cites W2119034557 @default.
• W2568967701 cites W2123526148 @default.
• W2568967701 cites W2130669171 @default.
• W2568967701 cites W2134984157 @default.
• W2568967701 cites W2136636834 @default.
• W2568967701 cites W2137413455 @default.
• W2568967701 cites W2141454098 @default.
• W2568967701 cites W2148643283 @default.
• W2568967701 cites W2159771669 @default.
• W2568967701 cites W2164121536 @default.
• W2568967701 cites W2166918329 @default.
• W2568967701 cites W2167363836 @default.
• W2568967701 cites W2167869791 @default.
• W2568967701 cites W2170552969 @default.
• W2568967701 cites W2495021631 @default.
• W2568967701 doi "https://doi.org/10.1080/0284186x.2016.1260772" @default.
• W2568967701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28068151" @default.
• W2568967701 hasPublicationYear "2017" @default.
• W2568967701 type Work @default.
• W2568967701 sameAs 2568967701 @default.
• W2568967701 citedByCount "23" @default.
• W2568967701 countsByYear W25689677012017 @default.
• W2568967701 countsByYear W25689677012018 @default.
• W2568967701 countsByYear W25689677012019 @default.
• W2568967701 countsByYear W25689677012020 @default.
• W2568967701 countsByYear W25689677012022 @default.
• W2568967701 countsByYear W25689677012023 @default.
• W2568967701 crossrefType "journal-article" @default.
• W2568967701 hasAuthorship W2568967701A5005198439 @default.
• W2568967701 hasAuthorship W2568967701A5005250000 @default.
• W2568967701 hasAuthorship W2568967701A5007575010 @default.
• W2568967701 hasAuthorship W2568967701A5030345469 @default.
• W2568967701 hasAuthorship W2568967701A5056829099 @default.
• W2568967701 hasAuthorship W2568967701A5058429184 @default.
• W2568967701 hasAuthorship W2568967701A5068091192 @default.
• W2568967701 hasAuthorship W2568967701A5070036041 @default.
• W2568967701 hasAuthorship W2568967701A5079802303 @default.
• W2568967701 hasAuthorship W2568967701A5087054688 @default.
• W2568967701 hasBestOaLocation W25689677011 @default.
• W2568967701 hasConcept C121608353 @default.
• W2568967701 hasConcept C126322002 @default.
• W2568967701 hasConcept C126894567 @default.
• W2568967701 hasConcept C143998085 @default.
• W2568967701 hasConcept C144301174 @default.
• W2568967701 hasConcept C181199279 @default.
• W2568967701 hasConcept C185592680 @default.
• W2568967701 hasConcept C207103383 @default.
• W2568967701 hasConcept C2777318727 @default.
• W2568967701 hasConcept C2777761686 @default.
• W2568967701 hasConcept C2778963024 @default.
• W2568967701 hasConcept C2780192828 @default.
• W2568967701 hasConcept C2781190966 @default.
• W2568967701 hasConcept C2781406297 @default.
• W2568967701 hasConcept C38180746 @default.
• W2568967701 hasConcept C44249647 @default.
• W2568967701 hasConcept C55493867 @default.
• W2568967701 hasConcept C71924100 @default.
• W2568967701 hasConcept C90924648 @default.
• W2568967701 hasConceptScore W2568967701C121608353 @default.
• W2568967701 hasConceptScore W2568967701C126322002 @default.
• W2568967701 hasConceptScore W2568967701C126894567 @default.
• W2568967701 hasConceptScore W2568967701C143998085 @default.
• W2568967701 hasConceptScore W2568967701C144301174 @default.
• W2568967701 hasConceptScore W2568967701C181199279 @default.
• W2568967701 hasConceptScore W2568967701C185592680 @default.
• W2568967701 hasConceptScore W2568967701C207103383 @default.
• W2568967701 hasConceptScore W2568967701C2777318727 @default.
• W2568967701 hasConceptScore W2568967701C2777761686 @default.
• W2568967701 hasConceptScore W2568967701C2778963024 @default.
• W2568967701 hasConceptScore W2568967701C2780192828 @default.
• W2568967701 hasConceptScore W2568967701C2781190966 @default.
• W2568967701 hasConceptScore W2568967701C2781406297 @default.
• W2568967701 hasConceptScore W2568967701C38180746 @default.
• W2568967701 hasConceptScore W2568967701C44249647 @default.

• next